000			01483 a2200385 4500
005			20250515091048.0
264		0	_c20080103
008			200801s 0 0 eng d
022			_a0021-8820
024	7		_a10.1038/ja.2007.72 _2doi
040			_aNLM _beng _cNLM
100	1		_aMurphy, Christopher K
245	0	0	_aIn vitro activity of novel rifamycins against gram-positive clinical isolates. _h[electronic resource]
260			_bThe Journal of antibiotics _cSep 2007
300			_a572-6 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAnti-Bacterial Agents _xpharmacology
650	0	4	_aCytochrome P-450 Enzyme System _xdrug effects
650	0	4	_aDrug Interactions
650	0	4	_aEnterococcus faecalis _xdrug effects
650	0	4	_aEnterococcus faecium _xdrug effects
650	0	4	_aGram-Positive Cocci _xdrug effects
650	0	4	_aMicrobial Sensitivity Tests
650	0	4	_aRifamycins _xpharmacology
650	0	4	_aStaphylococcus aureus _xdrug effects
650	0	4	_aStaphylococcus epidermidis _xdrug effects
650	0	4	_aStreptococcus agalactiae _xdrug effects
650	0	4	_aStreptococcus pneumoniae _xdrug effects
650	0	4	_aStreptococcus pyogenes _xdrug effects
700	1		_aKarginova, Elena
700	1		_aSahm, Dan
700	1		_aRothstein, David M
773	0		_tThe Journal of antibiotics _gvol. 60 _gno. 9 _gp. 572-6
856	4	0	_uhttps://doi.org/10.1038/ja.2007.72 _zAvailable from publisher's website
999			_c17438677 _d17438677